Articles
News, editorials, patient stories, and more.
This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or a qualified healthcare provider before making any health decisions. Full Disclaimer
COVID-19 and Hashimoto's: New Research Points to a Troubling Link
New clinical data from China suggests COVID-19 may trigger the onset of Hashimoto's thyroiditis in people with no prior thyroid history. If...
Read More — COVID-19 and Hashimoto's: New Research Points to a Troubling Link »A New Blood Test Could Cut the Nine-Year Diagnostic Wait for Ankylosing Spondylitis
Augurex Life Sciences has developed SPINEstat, a novel blood test that measures anti-14-3-3eta autoantibodies to distinguish inflammatory ba...
Read More — A New Blood Test Could Cut the Nine-Year Diagnostic Wait for Ankylosing Spondylitis »Inside the Inflamed Eye: A 2026 Review Explains How Autoimmune Uveitis Begins and How to Treat It
A comprehensive review published in Frontiers in Medicine traces the immune mechanisms behind autoimmune uveitis, one of the leading causes...
Read More — Inside the Inflamed Eye: A 2026 Review Explains How Autoimmune Uveitis Begins and How to Treat It »New Clinical Trial Explores Targeted Treatment for Myasthenia Gravis
New clinical trial investigates targeted immune therapy for myasthenia gravis.
Read More — New Clinical Trial Explores Targeted Treatment for Myasthenia Gravis »Cell Therapy for Sjögren's Disease Dry Mouth Earns FDA Fast Track Designation
Researchers at the University of Wisconsin are testing a novel cell therapy for dry mouth caused by Sjögren's disease. The FDA has granted...
Read More — Cell Therapy for Sjögren's Disease Dry Mouth Earns FDA Fast Track Designation »CAR T-Cell Therapy Achieves Full Remission in Patients With Treatment-Resistant Autoimmune Hemolytic Anemia
A clinical study published in the New England Journal of Medicine found that CD19-directed CAR T-cell therapy achieved complete remission in...
Read More — CAR T-Cell Therapy Achieves Full Remission in Patients With Treatment-Resistant Autoimmune Hemolytic Anemia »Emerging Sjögren’s Treatments Show Promise in Clinical Trials
Multiple new drugs targeting immune pathways are showing encouraging results in Sjögren’s clinical trials.
Read More — Emerging Sjögren’s Treatments Show Promise in Clinical Trials »Why Timely Diagnosis of Addison's Disease Is a Life-or-Death Matter
A clinical review in The Journal for Nurse Practitioners highlights why Addison's disease is so frequently missed and what needs to change t...
Read More — Why Timely Diagnosis of Addison's Disease Is a Life-or-Death Matter »ADEM: A Current Look at How the Brain Comes Under Immune Attack and What It Means for Patients
A comprehensive 2026 review synthesizes current understanding of how acute disseminated encephalomyelitis develops, how it is recognized cli...
Read More — ADEM: A Current Look at How the Brain Comes Under Immune Attack and What It Means for Patients »Gut-Derived Toxins May Play a Role in Triggering Hashimoto’s Thyroiditis
Researchers found elevated levels of bacterial toxins in people with Hashimoto’s thyroiditis, suggesting the gut microbiome may influence...
Read More — Gut-Derived Toxins May Play a Role in Triggering Hashimoto’s Thyroiditis »FDA Grants Breakthrough Therapy Status to Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to ianalumab, a potential targeted treatment for Sjögren’s disease.
Read More — FDA Grants Breakthrough Therapy Status to Ianalumab for Sjögren’s Disease »Scientists Pinpoint a 'Hot Spot' on the NMDA Receptor That Could Unlock Targeted Treatments for 'Brain on Fire' Disease
Researchers at Oregon Health & Science University have used near-atomic imaging to identify a precise cluster of binding sites on the NMDA r...
Read More — Scientists Pinpoint a 'Hot Spot' on the NMDA Receptor That Could Unlock Targeted Treatments for 'Brain on Fire' Disease »